Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar 30;11(4):311-31.
doi: 10.1038/nrd2909.

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Affiliations
Review

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

P Mark Hogarth et al. Nat Rev Drug Discov. .

Abstract

The direct or indirect targeting of antibody Fc receptors (FcRs) presents unique opportunities and interesting challenges for the treatment of inflammatory diseases, cancer and infection. Biological responses induced via the Fc portions of antibodies are powerful, complex and unusual, and comprise both activating and inhibitory effects. These properties can be exploited in the engineering of therapeutic monoclonal antibodies to improve their activity in vivo. FcRs have also emerged as key participants in the pathogenesis of several important autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. Therapeutic approaches based on antagonizing FcR function with small molecules or biological drugs such as monoclonal antibodies and recombinant soluble FcR ectodomains have gained momentum. This Review addresses various strategies to manipulate FcR function to overcome immune complex-mediated inflammatory diseases, and considers approaches to improve antibody-based anticancer therapies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blood. 2008 Jan 15;111(2):894-904 - PubMed
    1. Ann Rheum Dis. 2008 Feb;67(2):154-61 - PubMed
    1. Blood. 2011 Sep 1;118(9):2530-40 - PubMed
    1. FASEB J. 2009 Feb;23(2):575-85 - PubMed
    1. Trends Pharmacol Sci. 2009 Jul;30(7):356-62 - PubMed

Publication types

LinkOut - more resources